Showing 25 of 438 grants in "Health"
National Indian Health Outreach and Education
Deadline: November 2, 2026
Opportunity Number: HHS-2026-IHS-NIHOE-0001
Agency: Indian Health Service
Open Date: September 9, 2026
Close Date: November 2, 2026
Status: Posted
CFDA Numbers: 93.00L
Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations
Deadline: February 5, 2027
Opportunity Number: CDC-RFA-DP-27-0023
Agency: Centers for Disease Control - NCCDPHP
Open Date: September 3, 2026
Close Date: February 5, 2027
Status: Posted
CFDA Numbers: 93.898
Improving the Capacity of Tribal Communities to Identify Emerging Drug Threats
Deadline: September 13, 2026
Opportunity Number: RD-ET-RDA-26-002
Agency: Office of National Drug Control Policy
Open Date: September 2, 2026
Close Date: September 13, 2026
Status: Posted
CFDA Numbers: 95.007
NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed)
Deadline: April 17, 2029
Opportunity Number: PAR-27-051
Agency: National Institutes of Health
Open Date: September 1, 2026
Close Date: April 17, 2029
Status: Posted
CFDA Numbers: 93.853, 93.279, 93.121, 93.242, 93.273, 93.399
Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)
Deadline: July 16, 2028
Opportunity Number: PAR-27-096
Agency: National Institutes of Health
Open Date: September 1, 2026
Close Date: July 16, 2028
Status: Posted
CFDA Numbers: 93.361, 93.121, 93.307, 93.866
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not Allowed)
Deadline: June 12, 2028
Opportunity Number: PAR-27-112
Agency: National Institutes of Health
Open Date: September 1, 2026
Close Date: June 12, 2028
Status: Posted
CFDA Numbers: 93.866
Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
Deadline: November 10, 2026
Opportunity Number: RFA-AI-27-005
Agency: National Institutes of Health
Open Date: September 1, 2026
Close Date: November 10, 2026
Status: Posted
CFDA Numbers: 93.855
Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
Deadline: November 10, 2026
Opportunity Number: RFA-AI-27-002
Agency: National Institutes of Health
Open Date: September 1, 2026
Close Date: November 10, 2026
Status: Posted
CFDA Numbers: 93.855
Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)
Deadline: October 9, 2028
Opportunity Number: RFA-AI-27-014
Agency: National Institutes of Health
Open Date: September 1, 2026
Close Date: October 9, 2028
Status: Posted
CFDA Numbers: 93.839, 93.837, 93.853, 93.840, 93.846, 93.867, 93.855, 93.233, 93.279, 93.838
Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional)
Deadline: May 25, 2028
Opportunity Number: PAR-27-127
Agency: National Institutes of Health
Open Date: September 1, 2026
Close Date: May 25, 2028
Status: Posted
CFDA Numbers: 93.242
Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
Deadline: November 10, 2026
Opportunity Number: RFA-AG-27-010
Agency: National Institutes of Health
Open Date: September 1, 2026
Close Date: November 10, 2026
Status: Posted
CFDA Numbers: 93.866
Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)
Deadline: November 6, 2026
Opportunity Number: RFA-DK-27-125
Agency: National Institutes of Health
Open Date: August 31, 2026
Close Date: November 6, 2026
Status: Posted
CFDA Numbers: 93.847
Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
Deadline: November 9, 2026
Opportunity Number: RFA-DK-27-112
Agency: National Institutes of Health
Open Date: August 31, 2026
Close Date: November 9, 2026
Status: Posted
CFDA Numbers: 93.847
NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required)
Deadline: March 9, 2029
Opportunity Number: PAR-27-065
Agency: National Institutes of Health
Open Date: August 31, 2026
Close Date: March 9, 2029
Status: Posted
CFDA Numbers: 93.853
Cooperative Centers for Experimental Hematology (CCEHs) (U54- Clinical Trial Not Allowed)
Deadline: September 30, 2026
Opportunity Number: RFA-DK-27-127
Agency: National Institutes of Health
Open Date: August 31, 2026
Close Date: September 30, 2026
Status: Posted
CFDA Numbers: 93.847
Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
Deadline: October 1, 2026
Opportunity Number: RFA-CA-27-005
Agency: National Institutes of Health
Open Date: August 31, 2026
Close Date: October 1, 2026
Status: Posted
CFDA Numbers: 93.394, 93.395
BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed)
Deadline: June 23, 2028
Opportunity Number: RFA-NS-27-002
Agency: National Institutes of Health
Open Date: August 31, 2026
Close Date: June 23, 2028
Status: Posted
CFDA Numbers: 93.279, 93.242, 93.853, 93.867, 93.286, 93.372, 93.866, 93.865, 93.173, 93.213, 93.273
Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional)
Deadline: January 25, 2027
Opportunity Number: PAR-28-062
Agency: National Institutes of Health
Open Date: August 31, 2026
Close Date: January 25, 2027
Status: Posted
CFDA Numbers: 93.399
Limited Competition: NIGMS Mature Synchrotron Resources (MSR) for Structural Biology (P30 - Clinical Trial Not Allowed)
Deadline: October 2, 2028
Opportunity Number: PAR-27-068
Agency: National Institutes of Health
Open Date: August 31, 2026
Close Date: October 2, 2028
Status: Posted
CFDA Numbers: 93.859
Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional)
Deadline: July 7, 2028
Opportunity Number: PAR-27-076
Agency: National Institutes of Health
Open Date: August 31, 2026
Close Date: July 7, 2028
Status: Posted
CFDA Numbers: 93.855, 93.233, 93.838, 93.840, 93.879, 93.307, 93.839, 93.273, 93.372, 93.853, 93.310, 93.113, 93.173, 93.398, 93.847, 93.865, 93.242, 93.866, 93.121, 93.213, 93.837
Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
Deadline: November 9, 2026
Opportunity Number: RFA-DK-27-139
Agency: National Institutes of Health
Open Date: August 31, 2026
Close Date: November 9, 2026
Status: Posted
CFDA Numbers: 93.847
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
Deadline: June 16, 2028
Opportunity Number: PAR-27-053
Agency: National Institutes of Health
Open Date: August 31, 2026
Close Date: June 16, 2028
Status: Posted
CFDA Numbers: 93.279
Fiscal Year (FY) 2027 AmeriCorps State and National Competitive Grants
Deadline: January 13, 2027
Opportunity Number: AC-08-28-26
Agency: AmeriCorps
Open Date: August 28, 2026
Close Date: January 13, 2027
Status: Posted
CFDA Numbers: 94.006
Long-term health outcomes of people living with spina bifida
Deadline: October 26, 2026
Opportunity Number: CDC-RFA-DD-26-0222
Agency: Centers for Disease Control - NCBDDD
Open Date: August 26, 2026
Close Date: October 26, 2026
Status: Posted
CFDA Numbers: 93.073
Fiscal Year (FY) 2027 AmeriCorps Seniors RSVP Competition
Deadline: October 20, 2026
Opportunity Number: AC-08-20-2026
Agency: AmeriCorps
Open Date: August 20, 2026
Close Date: October 20, 2026
Status: Posted
CFDA Numbers: 94.002